Predictive Role of Interphase Cytogenetics for Survival of Patients With Multiple Myeloma
- 14 February 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (4), 804
- https://doi.org/10.1200/jco.2000.18.4.804
Abstract
PURPOSE: Recent metaphase cytogenetic studies suggested that specific chromosomal abnormalities are of prognostic significance in patients with multiple myeloma (MM). Because the true incidence of ...Keywords
This publication has 38 references indexed in Scilit:
- Total Therapy With Tandem Transplants for Newly Diagnosed Multiple MyelomaBlood, 1999
- Multiple MyelomaNew England Journal of Medicine, 1997
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- A new staging system for multiple myeloma based on the number of S- phase plasma cellsBlood, 1995
- Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma [see comments]Blood, 1993
- The prognostic value of serum β 2 microglobulin compared with other presentation features in myelomatosisBritish Journal of Cancer, 1985
- Multiple myeloma: significance of plasmablastic subtype in morphological classificationBlood, 1985
- Prognostic relevance of cellular morphology in multiple myelomaBlood, 1984
- Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and stagingBritish Journal of Haematology, 1982
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975